79 related articles for article (PubMed ID: 35890130)
1. Optimization of 2-Aminoquinazolin-4-(3
Shin YS; Lee JY; Jeon S; Cho JE; Myung S; Jang MS; Kim S; Song JH; Kim HR; Park HG; Jeong LS; Park CM
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890130
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of 2-aminoquinazolin-4(3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments.
Lee JY; Shin YS; Jeon S; Lee SI; Noh S; Cho JE; Jang MS; Kim S; Song JH; Kim HR; Park CM
Bioorg Med Chem Lett; 2021 May; 39():127885. PubMed ID: 33662537
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 2-benzylaminoquinazolin-4(3
Lee JY; Shin YS; Jeon S; Lee SI; Cho JE; Myung S; Jang MS; Kim S; Song JH; Kim HR; Park CM
Bull Korean Chem Soc; 2022 Mar; 43(3):412-416. PubMed ID: 35440837
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays.
Curreli F; Ahmed S; Victor SMB; Drelich A; Panda SS; Altieri A; Kurkin AV; Tseng CK; Hillyer CD; Debnath AK
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062273
[TBL] [Abstract][Full Text] [Related]
5. Anticoronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic Acid ABA from the Rhizome of
Jin YH; Jeon S; Lee J; Kim S; Jang MS; Park CM; Song JH; Kim HR; Kwon S
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214108
[TBL] [Abstract][Full Text] [Related]
6. RETRACTED ARTICLE: Discovery of (
Rabie AM
Chem Zvesti; 2021; 75(9):4669-4685. PubMed ID: 34025012
[TBL] [Abstract][Full Text] [Related]
7.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
8. Broad Spectrum Antiviral Properties of Cardiotonic Steroids Used as Potential Therapeutics for Emerging Coronavirus Infections.
Jin YH; Jeon S; Lee J; Kim S; Jang MS; Park CM; Song JH; Kim HR; Kwon S
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834252
[TBL] [Abstract][Full Text] [Related]
9. Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection
Curreli F; Victor SMB; Ahmed S; Drelich A; Tong X; Tseng CK; Hillyer CD; Debnath AK
mBio; 2020 Dec; 11(6):. PubMed ID: 33310780
[TBL] [Abstract][Full Text] [Related]
10. New chalcone derivatives as effective against SARS-CoV-2 agent.
Duran N; Polat MF; Aktas DA; Alagoz MA; Ay E; Cimen F; Tek E; Anil B; Burmaoglu S; Algul O
Int J Clin Pract; 2021 Dec; 75(12):e14846. PubMed ID: 34519118
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Biological Evaluation of Honokiol Derivatives Bearing 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)oxazol-2(3H)-ones as Potential Viral Entry Inhibitors against SARS-CoV-2.
Guo Y; Meng JR; Liu JZ; Xu T; Zheng ZY; Jiang ZH; Bai LP
Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577585
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 4'-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor.
Wu Q; Yan S; Wang Y; Li M; Xiao Y; Li Y
Biochem Biophys Res Commun; 2022 May; 604():76-82. PubMed ID: 35303682
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of diterpenic Mannich bases as antiviral agents against influenza A and SARS-CoV-2.
Tret'yakova EV; Ma X; Kazakova OB; Shtro AA; Petukhova GD; Klabukov AM; Dyatlov DS; Smirnova AA; Xu H; Xiao S
Phytochem Lett; 2022 Oct; 51():91-96. PubMed ID: 35935343
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
Dai W; Zhang B; Jiang XM; Su H; Li J; Zhao Y; Xie X; Jin Z; Peng J; Liu F; Li C; Li Y; Bai F; Wang H; Cheng X; Cen X; Hu S; Yang X; Wang J; Liu X; Xiao G; Jiang H; Rao Z; Zhang LK; Xu Y; Yang H; Liu H
Science; 2020 Jun; 368(6497):1331-1335. PubMed ID: 32321856
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2.
Dai W; Jochmans D; Xie H; Yang H; Li J; Su H; Chang D; Wang J; Peng J; Zhu L; Nian Y; Hilgenfeld R; Jiang H; Chen K; Zhang L; Xu Y; Neyts J; Liu H
J Med Chem; 2022 Feb; 65(4):2794-2808. PubMed ID: 33872498
[TBL] [Abstract][Full Text] [Related]
16. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S
Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462
[TBL] [Abstract][Full Text] [Related]
17. 2-Aminoquinazolin-4(3H)-one based plasmepsin inhibitors with improved hydrophilicity and selectivity.
Rasina D; Stakanovs G; Borysov OV; Pantelejevs T; Bobrovs R; Kanepe-Lapsa I; Tars K; Jaudzems K; Jirgensons A
Bioorg Med Chem; 2018 May; 26(9):2488-2500. PubMed ID: 29636223
[TBL] [Abstract][Full Text] [Related]
18. Bio-Guided Isolation of SARS-CoV-2 Main Protease Inhibitors from Medicinal Plants: In Vitro Assay and Molecular Dynamics.
Abdallah HM; El-Halawany AM; Darwish KM; Algandaby MM; Mohamed GA; Ibrahim SRM; Koshak AE; Elhady SS; Fadil SA; Alqarni AA; Abdel-Naim AB; Elfaky MA
Plants (Basel); 2022 Jul; 11(15):. PubMed ID: 35893619
[TBL] [Abstract][Full Text] [Related]
19. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S
J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312
[TBL] [Abstract][Full Text] [Related]
20. Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease:
Nutho B; Wilasluck P; Deetanya P; Wangkanont K; Arsakhant P; Saeeng R; Rungrotmongkol T
Comput Struct Biotechnol J; 2022; 20():2784-2797. PubMed ID: 35677603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
